These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 1972719)

  • 1. Vaccination with membrane-associated idiotype provides greater and more prolonged protection of animals from tumor challenge than the soluble form of idiotype.
    Ghosh SK; White LM; Ghosh R; Bankert RB
    J Immunol; 1990 Jul; 145(1):365-70. PubMed ID: 1972719
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Idiotype vaccination post-bone marrow transplantation for B-cell lymphoma: initial studies in a murine model.
    Kwak LW; Campbell M; Levy R
    Cancer Detect Prev; 1991; 15(4):323-5. PubMed ID: 1794139
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of humoral immune responses and tumor immunity in mice immunized with recombinant SV40 large tumor antigen and a monoclonal anti-idiotype.
    Shearer MH; Bright RK; Kennedy RC
    Cancer Res; 1993 Dec; 53(23):5734-9. PubMed ID: 7694794
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunoregulation by processed immunoglobulin on B-cells.
    Ghosh SK; Chakrabarti D
    Indian J Biochem Biophys; 1993 Dec; 30(6):414-21. PubMed ID: 7911781
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bispecific anti-idiotype/anti-CD3 antibody therapy of murine B cell lymphoma.
    Weiner GJ; Hillstrom JR
    J Immunol; 1991 Dec; 147(11):4035-44. PubMed ID: 1834746
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Trioma-based vaccination against B-cell lymphoma confers long-lasting tumor immunity.
    Mocikat R; Selmayr M; Thierfelder S; Lindhofer H
    Cancer Res; 1997 Jun; 57(12):2346-9. PubMed ID: 9192805
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Idiotype-specific T lymphocytes responsible for the selection of somatic variants of a B cell hybrid.
    Ghosh SK; Wong J; Bankert RB
    J Immunol; 1987 Apr; 138(7):2230-5. PubMed ID: 2951434
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Idiotype vaccination against murine B cell lymphoma. Inhibition of tumor immunity by free idiotype protein.
    Kaminski MS; Kitamura K; Maloney DG; Levy R
    J Immunol; 1987 Feb; 138(4):1289-96. PubMed ID: 3492546
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Idiotypic vaccination for B-cell malignancies as a model for therapeutic cancer vaccines: from prototype protein to second generation vaccines.
    Ruffini PA; Neelapu SS; Kwak LW; Biragyn A
    Haematologica; 2002 Sep; 87(9):989-1001. PubMed ID: 12217812
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Idiotype vaccination against murine B cell lymphoma. Humoral and cellular requirements for the full expression of antitumor immunity.
    Campbell MJ; Esserman L; Byars NE; Allison AC; Levy R
    J Immunol; 1990 Aug; 145(3):1029-36. PubMed ID: 2373859
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of a vaccine-induced anti-tumor B cell response by soluble protein antigen in the absence of continuing T cell help.
    Savelyeva N; King CA; Vitetta ES; Stevenson FK
    Proc Natl Acad Sci U S A; 2005 Aug; 102(31):10987-92. PubMed ID: 16037207
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased immunogenicity of tumor vaccines complexed with anti-Gal: studies in knockout mice for alpha1,3galactosyltransferase.
    LaTemple DC; Abrams JT; Zhang SY; Galili U
    Cancer Res; 1999 Jul; 59(14):3417-23. PubMed ID: 10416604
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-idiotypic antibodies recognizing stable epitopes limit the emergence of idiotype variants in a murine B cell lymphoma.
    Weiner GJ; Kaminski MS
    J Immunol; 1990 Mar; 144(6):2436-45. PubMed ID: 1690244
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumor-specific idiotype vaccines. III. Induction of T helper cells by anti-idiotype and tumor cells.
    Raychaudhuri S; Saeki Y; Chen JJ; Kohler H
    J Immunol; 1987 Sep; 139(6):2096-102. PubMed ID: 2442262
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Idiotype vaccination against murine B cell lymphoma. Humoral and cellular responses elicited by tumor-derived immunoglobulin M and its molecular subunits.
    Campbell MJ; Carroll W; Kon S; Thielemans K; Rothbard JB; Levy S; Levy R
    J Immunol; 1987 Oct; 139(8):2825-33. PubMed ID: 3498771
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Idiotype protein-pulsed dendritic cells produce strong anti-myeloma effects after syngeneic stem cell transplantation in mice.
    Zeis M; Frenzke H; Schmitz N; Uharek L; Steinmann J
    Bone Marrow Transplant; 2002 Feb; 29(3):213-21. PubMed ID: 11859393
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Generation of somatic variants of a B cell hybrid mediated by a non-cytolytic L3T4+ idiotype-specific T cell.
    Ghosh SK; Bankert RB
    J Immunol; 1989 Jan; 142(2):409-15. PubMed ID: 2463306
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Growth inhibition of a B cell leukemia: evidence implicating an anti-idiotype immune response for protective tumor immunity.
    Ciavarra RP; Vitetta ES; Forman J
    J Immunol; 1986 Aug; 137(4):1371-5. PubMed ID: 2426362
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Idiotypic intramolecular help. Induction of tumor-specific antibodies by monoclonal anti-idiotypic antibody with the help of Fc-specific T helper clones.
    Saeki Y; Chen JJ; Shi LF; Kohler H
    J Immunol; 1989 Apr; 142(8):2629-34. PubMed ID: 2522964
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Specificity of antigens on UV radiation-induced antigenic tumor cell variants measured in vitro and in vivo.
    Hostetler LW; Romerdahl CA; Kripke ML
    Cancer Res; 1989 Mar; 49(5):1207-13. PubMed ID: 2465081
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.